Lilly Says Volume Growth Strategy, Launches Working Despite Price Pressures

 
• By Joseph Haas

Trulicity, Taltz grew in the first quarter, but below analyst consensus estimates. Company points to price decreases as holding down growth.

Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV
Lilly posted 7% volume growth during the first quarter, but that was offset by pricing pressures

More from Earnings

More from Business